Evaluation of RPNI for Symptomatic Neuromas in Lower Limb Amputees

Recruiting Observational Study
Symptomatic Neuroma Phantom Limb Pain After Amputation Residual Limb Pain Neuropathic Pain Lower Extremity Amputations
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Observational
Participants needed
20 (estimated)
Sponsor
Saglik Bilimleri Universitesi · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This prospective, observational cohort study evaluates the long-term outcomes of Regenerative Peripheral Nerve Interface (RPNI) surgery in patients with major lower extremity amputations suffering from symptomatic neuromas. RPNI is a surgical technique where the transected nerve end is implanted into a free autologous muscle graft to serve as a physiological target for reinnervation. The study aim…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age: Adults aged 18 to 70 years. * Amputation Status: Unilateral major lower extremity amputation (Transtibial, Transfemoral, or Knee Disarticulation). * Radiological Baseline: Absence of Heterotopic Ossification (HO) in the residual limb, confirmed by pre-operative X-rays (Wa…
Contacts

Ahmet Burak Bilekli, MD, Associate Professor

+905326007020

draburakbilekli@yahoo.com

CONTACT

Muhammed Burak Polat, MD

+90 545 340 73 23

draburakbilekli@yahoo.com

CONTACT